Amyloid beta from axons and dendrites reduces local spine number and plasticity

Nature Neuroscience

Volumn 13, Issue 2, 2010, Pages 190-196

  Wei, Wei ^a,b   Nguyen, Louis N ^b   Kessels, Helmut W ^b   Hagiwara, Hiroaki ^b   Sisodia, Sangram ^c   Malinow, Roberto ^a,b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR;

ACTION POTENTIAL; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; DENSITY; NERVE CELL PLASTICITY; NERVE FIBER; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SYNAPSE;

ACTION POTENTIALS; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONS; DENDRITES; DENDRITIC SPINES; HIPPOCAMPUS; NEURONAL PLASTICITY; PEPTIDE FRAGMENTS; PYRAMIDAL CELLS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SYNAPSES; TIME FACTORS;

EID: 75549092259     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2476     Document Type: Article

References (50)

1. Terry, R.D. et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580 (1991).
2. Walsh, D.M. & Selkoe, D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193 (2004).
3. Lacor, P.N. et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24, 10191-10200 (2004).
4. Hsieh, H. et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
5. Shankar, G.M. et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866-2875 (2007).
6. Shrestha, B.R. et al. Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Mol. Cell. Neurosci. 33, 274-282 (2006).
7. Calabrese, B. et al. Rapid, concurrent alterations in pre-and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol. Cell. Neurosci. 35, 183-193 (2007).
8. Evans, N.A. et al. Abeta(1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis. J. Neurosci. Methods 175, 96-103 (2008).
9. Lacor, P.N. et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796-807 (2007).
10. Lanz, T.A., Carter, D.B. & Merchant, K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13, 246-253 (2003).
11. Jacobsen, J.S. et al. Early-onset behavioral and synaptic defcits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103, 5161-5166 (2006).
12. Spires, T.L. et al. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 25, 7278-7287 (2005).
13. Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925-937 (2003).
14. Snyder, E.M. et al. Regulation of NMDA receptor traffcking by amyloid-beta. Nat. Neurosci. 8, 1051-1058 (2005).
15. Almeida, C.G. et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20, 187-198 (2005).
16. Ting, J.T., Kelley, B.G., Lambert, T.J., Cook, D.G. & Sullivan, J.M. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc. Natl. Acad. Sci. USA 104, 353-358 (2007).
17. Walsh, D.M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002).
18. Chapman, P. F. et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276 (1999).
19. Stéphan, A., Laroche, S. & Davis, S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory defcits. J. Neurosci. 21, 5703-5714 (2001).
20. Cleary, J.P. et al. Natural oligomers of the amyloid-beta protein specifcally disrupt cognitive function. Nat. Neurosci. 8, 79-84 (2005).
21. Klyubin, I. et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 11, 556-561 (2005).
22. Hartman, R.E. et al. Treatment with an amyloid-beta antibody ameliorates plaque load, learning defcits and hippocampal long-term potentiation in a mouse model of Alzheimer's disease. J. Neurosci. 25, 6213-6220 (2005).
23. Walsh, D.M. et al. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fbrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J. Neurosci. 25, 2455-2462 (2005).
24. Morgan, D. et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985 (2000).
25. Kopec, C.D., Li, B., Wei, W., Boehm, J. & Malinow, R. Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation. J. Neurosci. 26, 2000-2009 (2006).
26. Engert, F. & Bonhoeffer, T. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399, 66-70 (1999).
27. Maletic-Savatic, M., Malinow, R. & Svoboda, K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 283, 1923-1927 (1999).
28. Matsuzaki, M., Honkura, N., Ellis-Davies, G.C. & Kasai, H. Structural basis of long-term potentiation in single dendritic spines. Nature 429, 761-766 (2004).
29. Cirrito, J.R. et al. Synaptic activity regulates interstitial fuid amyloid-beta levels in vivo. Neuron 48, 913-922 (2005).
30. Buckner, R.L. et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709-7717 (2005).
31. Lazarov, O., Lee, M., Peterson, D.A. & Sisodia, S.S. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci. 22, 9785-9793 (2002).
32. Buxbaum, J.D. et al. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J. Neurosci. 18, 9629-9637 (1998).
33. Koo, E.H. et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. USA 87, 1561-1565 (1990).
34. Ferreira, A., Caceres, A. & Kosik, K.S. Intraneuronal compartments of the amyloid precursor protein. J. Neurosci. 13, 3112-3123 (1993).
35. Sisodia, S.S., Koo, E.H., Hoffman, P.N., Perry, G. & Price, D.L. Identifcation and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J. Neurosci. 13, 3136-3142 (1993).
36. Xia, W. et al. A specifc enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch. Neurol. 66, 190-199 (2009).
37. Kaether, C., Skehel, P. & Dotti, C.G. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol. Biol. Cell 11, 1213-1224 (2000).
38. Shankar, G.M. et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842 (2008).
39. Otmakhov, N. et al. Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. J. Neurophysiol. 91, 1955-1962 (2004).
40. Changeux, J.P., Kasai, M. & Lee, C.Y. Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc. Natl. Acad. Sci. USA 67, 1241-1247 (1970).
41. Small, S.A. & Gandy, S. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron 52, 15-31 (2006).
42. Sheng, J.G., Price, D.L. & Koliatsos, V.E. Disruption of corticocortical connections ameliorates amyloid burden in terminal felds in a transgenic model of Abeta amyloidosis. J. Neurosci. 22, 9794-9799 (2002).
43. Klyubin, I. et al. Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J. Neurosci. 28, 4231-4237 (2008).
44. Jones, I.W., Barik, J., O'Neill, M.J. & Wonnacott, S. Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors. J. Neurosci. Methods 134, 65-74 (2004).
45. Fabian-Fine, R. et al. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci. 21, 7993-8003 (2001).
46. Dineley, K.T., Bell, K.A., Bui, D. & Sweatt, J.D. Beta-amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Biol. Chem. 277, 25056-25061 (2002).
47. Dani, J.A. & Bertrand, D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47, 699-729 (2007).
48. Raschetti, R., Albanese, E., Vanacore, N. & Maggini, M. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomized trials. PLoS Med. 4, e338 (2007).
49. Coan, E.J., Irving, A.J. & Collingridge, G.L. Low-frequency activation of the NMDA receptor system can prevent the induction of LTP. Neurosci. Lett. 105, 205-210 (1989).
50. Molnár, Z. et al. Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. Neuroreport 15, 1649-1652 (2004).